Maya Koronyo-Hamaoui, PhD, Cedars-Sinai Medical Center, Los Angeles, CA, gives an overview of the imaging techniques available to study the retina in Alzheimer’s disease. These techniques are still investigational, and non-FDA approved but have been used, tested and validated by several research groups worldwide. Specifically, she comments on retinal amyloid imaging using fluorescence signals to look at amyloid beta plaques, which can be correlated with mild cognitive impairment and hippocampus atrophy. Other techniques discussed include the use of a modified laser scanning ophthalmoscope, the optical coherence tomography angiography and hyperspectral imaging. This interview took place during the Alzheimer’s Research UK (ARUK) Conference 2021.
Founding member and consultant of NeuroVision Imaging (NVI)